Home › Funds › CASTLEARK MANAGEMENT LLC › ASND

CASTLEARK MANAGEMENT LLC position in ASND

ASCENDIS PHARMA A/S · Health Care

CASTLEARK MANAGEMENT LLC reported holding 61,696 shares of ASND (ASCENDIS PHARMA A/S) in its Q2 2026 13F filing — a position valued at US$16.5M, representing 0.44% of its reported portfolio and ranking #41 among its reported holdings. CASTLEARK MANAGEMENT LLC has disclosed ASND holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)61.70K sh
Reported value held$16.46M
Portfolio Weight0.44%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CASTLEARK MANAGEMENT LLC's ASND position evolved

CASTLEARK MANAGEMENT LLC first disclosed a stake in ASND in Q3 2025 at 42,656 shares (US$8.5M). The position peaked in Q2 2026 at 61,696 shares, worth US$16.5M. Across 4 filings, CASTLEARK MANAGEMENT LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 61,696 shares valued at US$16.5M — a reduction of -5,920 shares quarter over quarter.. Notable position changes include a 56% increase in Q4 2025 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 42.66K $8.48M New
Q4 2025 66.34K $14.15M Add
Q1 2026 67.62K $15.47M Add
Q2 2026 61.70K $16.46M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 43 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has CASTLEARK MANAGEMENT LLC held ASND?

CASTLEARK MANAGEMENT LLC has disclosed ASND holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is CASTLEARK MANAGEMENT LLC's current position in ASND?

As of Q2 2026, CASTLEARK MANAGEMENT LLC holds 61.70K shares of ASND (ASCENDIS PHARMA A/S), valued at $16.46M, representing 0.44% of its reported portfolio and ranking #41.

Has CASTLEARK MANAGEMENT LLC been buying or selling ASND?

In the latest 13F filing (Q2 2026), CASTLEARK MANAGEMENT LLC reduced its position in ASND. The position peaked in Q2 2026 at 61.70K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.